Drug-maker Merck and Co. knows the dangers of the blockbuster drug model all too well.

Or a target can be less precise; for example, Merck’s 1979 target of becoming “the pre-eminent drug-maker worldwide in the 1980s”.

Sometimes it requires a drug maker to create and market a whole new category of disease.